Abstract
BackgroundOff-label use of drug-eluting stents (DES) is more common than on-label use and may be associated with a persistently higher rate of adverse angiographic and clinical outcomes.ObjectiveTo evaluate the safety...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have